Hjem › Steatotisk leversykdom › California
Kliniske studier for Steatotisk leversykdom i California
22 studier for Steatotisk leversykdom søker deltakere på steder i California.
Byer i California
- San Diego14 studier
- Pasadena8 studier
- Los Angeles8 studier
- Lancaster7 studier
- Orange5 studier
- San Francisco5 studier
- Huntington Beach5 studier
- Fresno5 studier
- Rialto5 studier
- Long Beach4 studier
- Folsom4 studier
- Escondido3 studier
- Sacramento3 studier
- Santa Maria3 studier
- Simi Valley3 studier
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Camarillo
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- og 10 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 89bio Clinical Study Site, Escondido
- og 13 flere
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06318169A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Southern California Research Center, Coronado
- California Liver Research Institute, Pasadena
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of California San Diego NAFLD Research Center, La Jolla
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
- og 2 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Southern California Research Center, Coronado
- Om Research Llc, Lancaster
- Clinnova Research Solutions, Orange
- og 3 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- San Fernando Valley Health Institute, Canoga Park
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Fresno Clinical Research Center, Fresno
- og 11 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Coronado
- Akero Clinical Study Site, Escondido
- Akero Clinical Study Site, Folsom
- og 13 flere
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Los Angeles
- og 3 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Om Research, Apple Valley
- ARK Clinical Research - Fountain Valley, Fountain Valley
- UCSD Medical Center, La Jolla
- og 4 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Coronado
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Los Angeles
- og 3 flere
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Folsom
- og 6 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Fresno
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Pasadena
- og 2 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Rialto
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 9. jun. 2026 · NCT07358546Bicalutamide Therapy in Young Women With NAFLD and PCOS
- University of California San Francisco, San Francisco
RekruttererFase 1
Alder 18 til 42 · Kvinner · Oppdatert 29. mai 2026 · NCT05979389A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Velocity Clinical research, Los Angeles
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 til 75 · Alle kjønn · Oppdatert 16. apr. 2026 · NCT05648214Androgens and NAFLD Longitudinal Cohort Study
- University of California San Francisco, San Francisco
RekruttererObservasjonsstudie
Alder 18 til 42 · Kvinner · Oppdatert 13. apr. 2026 · NCT06124261Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- University of California San Diego, La Jolla
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT07518784Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
- University of California San Diego, La Jolla
RekruttererObservasjonsstudie
Alder 9 til 18 · Alle kjønn · Oppdatert 21. jan. 2026 · NCT06706856Implementing Food Referrals for Equity and Sustained Health
- Rady Children's Hospital San Diego, San Diego
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
Alder 5 og eldre · Alle kjønn · Oppdatert 19. nov. 2025 · NCT06661538Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 35 til 65 · Alle kjønn · Oppdatert 4. des. 2024 · NCT05165706Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.